focus -WSS

focus

author：leisure time 2025-09-07 04:07:10 - browse：86293

What happens when a common virus jumps from birds to cows? And should we be concerned?

This week on “The Readout LOUD,” STAT senior infectious diseases reporter Helen Branswell walks us through ongoing H5N1 outbreak in the U.S. and issues with monitoring the spread.

It’s also Pulitzer week at “The Readout LOUD”! In a bit of shameless self-promotion, we’ll talk to our colleagues Bob Herman and Casey Ross about being named Pulitzer finalists in investigative reporting for their reporting on United Healthcare’s use of algorithms in coverage decisions. We’ll hear what’s happened since their explosive work was published last year.

To read all of Helen’s coverage on the H5N1 outbreak, go here; here’s more on how UnitedHealth Group used an unregulated algorithm in coverage decisions; and you can sign up for Adam’s new newsletter, Biotech Scorecard, here.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： How doctors’ personal politics affect patients

Wikipedia

WSS

There's an unseen cost to disruptive road

What it's like to live with paralysis for one psychologist

Will the FTC rein in IQVIA's health data empire?

What it's like to live with paralysis for one psychologist

The inclusion problem at the heart of rehabilitation research

FDA sets aggressive timeline for overhauling inspection procedures

knowledge

focus

focus

Medicare proposal to cover medical devices draws a mixed reaction

Future doctors need a strong humanities education

Supreme Court strikes down use of affirmative action

There's an unseen cost to disruptive road

Virginia high school admissions case could be legal follow

There's an unseen cost to disruptive road

Activists slam private health insurers over coverage restrictions

There's an unseen cost to disruptive road

Medicare details structure of new drug price negotiation program

Biogen says it will cut costs by $700 million, slash 1,000 jobs

entertainment

STAT Report: Patient voices and perspectives

The inclusion problem at the heart of rehabilitation research

What to watch for from Zogenix and Amicus clinical trials

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

UHS says company favors patients whose insurance pays more

Flu vaccine reformulation won't be easy, manufacturers warn

Wikipedia

hotspot

Wikipedia

focus